Shengnuo Biotech announced that its wholly-owned subsidiary Chengdu Shengnuo Biopharmaceutical Co., Ltd. recently received a “Drug Registration Certificate” for posaconazole injections issued by the State Drug Administration.
圣诺生物：泊沙康唑注射液获得药品注册证书
Shengnuo Biotech: Posaconazole injection obtained drug registration certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.